| Size | Price | |
|---|---|---|
| 1mg | ||
| 5mg | ||
| 10mg | ||
| Other Sizes |
| Targets |
Not applicable. 8-Chloroquinazolin-4-ol is a chemical scaffold and synthetic building block, not a drug with a specific biological target. Quinazolinone derivatives are known to exhibit diverse pharmacological activities, including anticancer (EGFR tyrosine kinase inhibition), antimicrobial, and anti-inflammatory properties. However, this specific derivative is primarily used as a precursor for chemical synthesis rather than as a direct-acting pharmacological agent.
|
|---|---|
| ln Vitro |
8-Chloroquinazolin-4-ol is a derivative of quinazolin-4(3H)-one, a heterocyclic scaffold widely used in medicinal chemistry. The biological activity of this scaffold is typically associated with inhibition of various protein kinases, including EGFR (epidermal growth factor receptor) and other tyrosine kinases. However, specific in vitro activity data for 8-Chloroquinazolin-4-ol itself is not provided in the available literature. The 4-oxo group is essential for the kinase inhibitory activity of quinazoline-based compounds.
|
| ln Vivo |
No specific in vivo data was found for 8-Chloroquinazolin-4-ol. The compound is a synthetic intermediate and building block. The in vivo activity, if any, would be associated with the final drug molecules synthesized from this scaffold. As a research chemical, it is not intended for in vivo administration; its use is limited to ex vivo chemical synthesis.
|
| Enzyme Assay |
Not applicable. 8-Chloroquinazolin-4-ol is a synthetic intermediate, not a test compound in enzyme binding assays. A typical assay for quinazoline-based EGFR inhibitors: The active compound (derived from this scaffold) is tested for kinase inhibition. Recombinant EGFR kinase (0.1-1 ng/well) is incubated with 50 microM ATP and 0.2 mg/mL poly(Glu, Tyr) substrate in kinase buffer. Varying concentrations of the inhibitor (0.001-10,000 nM) are added. Phosphorylation is measured by ELISA using an anti-phosphotyrosine antibody.
|
| Cell Assay |
Not applicable. 8-Chloroquinazolin-4-ol is a chemical building block for organic synthesis, not a compound tested directly in cell-based pharmacological assays. It is used as a starting material to synthesize more complex molecules that may have biological activity. For example, a derivative might be tested in cancer cell lines to evaluate its antiproliferative activity against EGFR-overexpressing cells such as A431 or HCC827 cells.
|
| Animal Protocol |
Not applicable. 8-Chloroquinazolin-4-ol is a synthetic building block used in medicinal chemistry and organic synthesis. It is not administered to animals as a drug. The compound is intended for chemical reactions such as alkylation, acylation, or nucleophilic substitution to introduce various functional groups. It is a research reagent for the preparation of bioactive quinazolinone derivatives, not a drug candidate.
|
| ADME/Pharmacokinetics |
Not applicable. Pharmacokinetic studies are not performed on 8-Chloroquinazolin-4-ol, as it is a synthetic intermediate, not a drug candidate. The ADME properties would be determined for the final drug molecule that is synthesized using this scaffold. This compound is a chemical building block and is not intended for systemic administration.
|
| Toxicity/Toxicokinetics |
No toxicity data was found for 8-Chloroquinazolin-4-ol. As a synthetic intermediate, it should be handled with standard chemical safety precautions. The chlorinated quinazoline structure suggests potential for chemical reactivity, and appropriate protective equipment (gloves, goggles, lab coat) should be used when handling this compound. A thorough risk assessment should be performed before use.
|
| References | |
| Additional Infomation |
8-Chloroquinazolin-4-ol (also known as 8-chloroquinazolin-4(3H)-one) is a research-grade heterocyclic compound. Its molecular formula is C8H5ClN2O and molecular weight is 180.59. It appears as a solid and is soluble in DMSO and DMF. This product is intended for laboratory research and chemical synthesis applications only, not for human or veterinary use. Store in a cool, dry place, protected from light and moisture.
|
| Molecular Formula |
C8H5CLN2O
|
|---|---|
| Molecular Weight |
180.59
|
| Exact Mass |
180.009
|
| CAS # |
101494-95-5
|
| PubChem CID |
135412869
|
| Appearance |
Solid powder
|
| Density |
1.5±0.1 g/cm3
|
| Boiling Point |
359.9±22.0 °C at 760 mmHg
|
| Flash Point |
171.5±22.3 °C
|
| Vapour Pressure |
0.0±0.8 mmHg at 25°C
|
| Index of Refraction |
1.71
|
| LogP |
1
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
12
|
| Complexity |
229
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
ClC1=C2N=CNC(=O)C2=CC=C1
|
| InChi Key |
JWLJDRWZFALRKE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C8H5ClN2O/c9-6-3-1-2-5-7(6)10-4-11-8(5)12/h1-4H,(H,10,11,12)
|
| Chemical Name |
8-chloro-3H-quinazolin-4-one
|
| Synonyms |
8-Chloro-4-quinazolinone
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~5 mg/mL (~27.69 mM; with ultrasonication (<60°C))
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.5 mg/mL (2.77 mM)(saturation unknown) in 10% DMSO 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one),clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution and add it to 900 μL corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.5374 mL | 27.6870 mL | 55.3741 mL | |
| 5 mM | 1.1075 mL | 5.5374 mL | 11.0748 mL | |
| 10 mM | 0.5537 mL | 2.7687 mL | 5.5374 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
